The medical humanitarian organisation Médecins Sans Frontières (MSF) is deeply concerned about the implications of the current economic crisis in Swaziland on people living with HIV/AIDS. To pre-empt stock ruptures, which are already affecting patients, MSF has supplied a contingency stock of...
Excluded countries should be ready to issue compulsory licences to access needed drugs An agreement announced today by pharmaceutical company Gilead to licence several HIV/AIDS drugs to the Medicines Patent Pool could improve access to medicines for patients, but excludes several countries with...
Funds and affordable drugs needed to turn target into treatment On the heels of new evidence that shows HIV treatment is also HIV prevention, governments meeting at a UN Summit on AIDS have taken a critical step by committing to reach 15 million people with HIV treatment by 2015 – but they must...
Latest Research Shows Expanded Treatment Could Turn AIDS Tide At a time when HIV treatment has proven to reduce HIV transmission by 96 percent, governments meeting for the UN Summit on AIDS must agree today to put nine million people on treatment over the next four years, despite strong opposition...
Governments must commit to massively scale up treatment at UN Summit on AIDS Governments will meet at the United Nations in New York for an HIV/AIDS Summit from 8 to 10 June, to discuss the global response to the epidemic over the next five to ten years. Hanging in the balance will be the lives of...
The prototype of a new tool for rapidly measuring the viral load of HIV, named SAMBA (Simple AMplification Based Assay), is currently being evaluated at our AIDS programme in Chiradzulu in Malawi. If the results of this trial are positive, the implementation of this test will represent a net...
Pharmaceutical giant’s refusal to participate in patent pool undermines access to key AIDS drugs > Click here to Tell Johnson & Johnson to join the patent pool Pharmaceutical giant Johnson & Johnson is putting the lives of people living with HIV at stake by refusing to participate in the...
Tuberculosis: progress in screening, South Sudan: A nation facing major challenges, Fistula: The backyard disease, Mali: vaccinating against meningitis epidemics, HIV/AIDS -- marching for generics
